glp 1 agonist microdosing GLP-1 Microdosing Tirzepatide and Semaglutide for

Decreased mortality, anti-inflammatory properties and neuroprotective effects can be beneficial in chronic substance use which is associated with neuroinflammation and oxidative stress

GLP-1R, GIPR, GCGR activation Each peptide was tested for its ability to activate GLP-1R, GIPR, or GCGR in a cell-based cAMP-responsive element luciferase reporter assay following the method of Kuna et.al (22)

Other GLP-1 receptor agonist products are used off-label for weight loss

Loyo and colleagues recently reviewed the United States Veterans Health Administration database, and identified 121,174 patients with T2DM and ischemic heart disease, cerebrovascular disease, or peripheral arterial disease who had been prescribed SGLT2is, GLP-1RAs, or their combination

Gudbergsen, H

Potential mechanisms include improvements in blood pressure, lipid profiles, body weight, inflammation, and endothelial function as well as direct cardioprotective effects on the cardiac muscle and vasculature [41]